Showing results (2351-2360 of 2,548) with videos related to

Sort By:
Pageof 255
Heart (British Cardiac Society)|April 1, 2018
Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trialThomas Engstrøm, Lars Nepper-Christensen, Steffen Helqvist, et al.
European Heart Journal. Acute Cardiovascular Care|October 14, 2022
Extracorporeal cardiopulmonary resuscitation: a national study on the association between favourable neurological status and biomarkers of hypoperfusion, inflammation, and organ injuryEmilie Gregers, Sivagowry Rasalingam Mørk, Louise Linde, et al.
Circulation|February 5, 2025
Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation LesionsSandeep Arunothayaraj, Mohaned Egred, Adrian P Banning, et al.
Circulation. Cardiovascular Interventions|April 16, 2024
Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction: The PiCSO-AMI-I TrialGiovanni Luigi De Maria, John P Greenwood, Azfar G Zaman, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 1, 2026
The Triglycerides, Total Cholesterol and Body Weight Index (TCBI) in acute heart failure - a post-hoc analysis of a prospective cohort studyMikkel Høgholm Pedersen, Filip Soeskov Davidovski, Caroline Espersen, et al.
European Heart Journal. Cardiovascular Imaging|April 4, 2017
Randomized comparison of sirolimus eluting, and biolimus eluting bioresorbable polymer stents: the SORT-OUT VII optical coherence tomography studyLene N Andreasen, Niels R Holm, Ida R Balleby, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 20, 2023
Bifurcation left main stenting with or without intracoronary imaging: Outcomes from the EBC MAIN trialAnnette Maznyczka, Sandeep Arunothayaraj, Mohaned Egred, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2014
A phase I monotherapy study of RG7212, a first-in-class monoclonal antibody targeting TWEAK signaling in patients with advanced cancersUlrik N Lassen, Didier Meulendijks, Lilian L Siu, et al.
The New England Journal of Medicine|July 3, 2009
Preoperative staging of lung cancer with combined PET-CTBarbara Fischer, Ulrik Lassen, Jann Mortensen, et al.
Pageof 255